Astrazeneca Plc (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1995 | 12-1994 | 12-1993 | 12-1992 | 12-1991 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 0 | N/A | 713,000 | N/A | N/A |
| Depreciation Amortization | 0 | N/A | 172,000 | N/A | N/A |
| Other Working Capital | 0 | N/A | 69,000 | N/A | N/A |
| Other Operating Activity | 0 | 0 | -374,000 | 0 | 0 |
| Operating Cash Flow | $0 | $N/A | $580,000 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | N/A | -313,000 | N/A | N/A |
| Other Investing Activity | 0 | 0 | 133,000 | 0 | 0 |
| Investing Cash Flow | $0 | $N/A | $-180,000 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | 0 | N/A | -186,000 | N/A | N/A |
| Other Financing Activity | 0 | 0 | 454,000 | 0 | 0 |
| Financing Cash Flow | $0 | $N/A | $268,000 | $N/A | $N/A |
| End Cash Position | 0 | N/A | 668,000 | N/A | N/A |
| Net Cash Flow | $0 | $N/A | $668,000 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 0 | N/A | 580,000 | N/A | N/A |
| Free Cash Flow | 0 | 0 | 580,000 | 0 | 0 |